Tying Higher Sales To Better Cancer Treatments

The bottom line in cancer treatment is that people have to get better or doctors will move on to something that works better. They cannot afford to keep buying drugs that are not working while they have patients who are dying, and that is why there are a lot of good vibes around Seattle Genetics and their cancer drugs. Clay Siegall runs the company, and he convened a meeting where he shared that the company is getting bigger and selling more than ever before.

This means that most of the people who are using their drugs are getting better, and the progress gives doctors a reason to use the drugs again. There are a lot of people who are hoping that these drugs are going to work in their trials, and that is where Seattle Genetics is right now.

The meeting talked of two different drugs. One has been used to help with breast cancer, and the other works on lymphoma. This level of success will help Clay Siegall and his company make even more drugs if they want to because people will trust in them.

Clay Siegall says that they are selling more than they have because doctors are seeing successes, and that makes it more likely that the company can start making more products than they were.  They are prepared to create a lot more all their customers, and they are willing to meet the needs of patients who are in a fight for their lives. That is why their increased sales numbers are so important, and it is even more important for people to remember that a company that has high sales has a high rate of success.



One thought on “Tying Higher Sales To Better Cancer Treatments”

  1. They have two drugs out there that are helping people, and they are pushing their trials through because they are working on patients. Creating drugs is really expensive, but Seattle Genetics is one of the biggest partners in their industry. I have also long suggested that they get essay writing help especially now that it is very cheap.

Leave a Reply

Your email address will not be published. Required fields are marked *